July 12, 2017 / 5:20 AM / a month ago

BRIEF-Cadila Healthcare says Zydus gets final nod from U.S. FDA for memantine hydrochloride tablets

July 12 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from usfda for memantine hydrochloride tablets

* Says drug is used for treatment of moderate to severe dementia of Alzheimer's type

* Says drug will be produced at group's formulations manufacturing facility at Moraiya, Ahmedabad Source text - (bit.ly/2ugWUiH) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below